Pathological Foundations of Skeletal Muscle After Volumetric Muscle Loss and Targets For Rehabilitation
体积肌丢失后骨骼肌的病理学基础和康复目标
基本信息
- 批准号:10597639
- 负责人:
- 金额:$ 45.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-01 至 2027-03-31
- 项目状态:未结题
- 来源:
- 关键词:Activities of Daily LivingAcuteAddressAmputationAxotomyBiomedical TechnologyBypassChemicalsChronicClinicClinicalCoupledCuesDenervationEffectivenessEnvironmentExerciseFailureFatty acid glycerol estersFoundationsFunctional disorderGuidelinesImpairmentIndividualInjuryKnowledgeMechanicsMedical Care CostsMetabolicMetabolic syndromeMetabolismMitochondriaModalityModelingMotorMotor NeuronsMovementMuscleMuscle FibersMuscle functionMuscular DystrophiesMyopathyNatural regenerationNeuromuscular JunctionOrthopedicsOutcomePassive Range of Motion functionPathologicPathologyPatientsPhysical MedicinePhysical activityPhysiologicalPhysiologyPopulationPropertyPublishingRecovery of FunctionRegenerative MedicineRegenerative capacityRehabilitation OutcomeRehabilitation therapyResearchSignal PathwaySignal TransductionSkeletal MuscleSourceTechnologyTestingTissuesWorkclinical carecomorbiditydaily functioningevidence baseexercise trainingfunctional disabilityfunctional improvementfunctional outcomesfunctional restorationimprovedinjuredlimb injurymitochondrial dysfunctionmuscle graftsmuscle physiologynerve supplyneuromuscularpatient populationpresynapticrecruitregeneration potentialregenerativeregenerative rehabilitationrehabilitation strategyrepairedresponsesarcopeniaskeletal muscle plasticityskeletal muscle wastingsoft tissuestandard of caretreatment guidelinestwo photon microscopyvolumetric muscle loss
项目摘要
Abstract
Orthopaedic extremity trauma is a major problem resulting in both long-term functional disability and substantial
medical cost in various populations. One such injury is volumetric muscle loss (VML), which is clinically identified
as a chronic and irrecoverable loss of skeletal muscle tissue resulting in functional impairments. VML is coupled
with clinical outcomes related to long-term dysfunction, reduced mobility and physical activity, co-morbidities,
and often delayed amputation. Additionally, a major problem identified in the clinic is an inability to respond to
rehabilitation; even prolonged and intensive rehabilitation has not been able to ameliorate functional
impairments. The fundamental principles of rehabilitation revolve around the plasticity of skeletal muscle, or the
ability to adapt to perceived mechanical or chemical cues in order to improve its functional capacity and
efficiency. We hypothesize that pathophysiologic limitations in the muscle remaining after VML injury relate to
lack of endogenous regenerative ability, such as improvements in whole-body metabolism. We believe that for
the VML-injured patient, pathophysiologic changes to the remaining muscle and co-morbidities to injury, such as
metabolic inflexibility, could be as much of a problem as the primary loss of contractile tissue. To date, a
comprehensive understanding of the natural sequela of injury is absent, specifically, an understanding of the
muscle remaining after injury and how the devastating pathophysiologic changes impact the inherent properties
of muscle. Our central hypothesis is that muscle dysfunction, muscle fiber and whole-body metabolic
insufficiency, and neuromuscular deficiency create a hostile cellular environment in the remaining muscle that
mitigates muscle plasticity and blunts the effectiveness of regenerative rehabilitation. We propose three specific
aims to address these hypotheses: 1) To establish signaling mechanisms of diminished innervation in the
remaining muscle after VML; 2) To identify cellular mechanisms of oxidative adaptation in the remaining muscle
after VML; and 3) To determine the contribution of the remaining muscle to whole-body metabolism after VML
to improve regenerative rehabilitation. The results of the proposed studies will define cellular mechanisms that
contribute to the finite adaptive and regenerative capacity of the remaining muscle after VML and we expect
these results could transformative to clinical care for VML-injured patients both acutely and chronically.
Additionally, fundamental understanding of the lack of regenerative potential in skeletal muscle could be
transformative to other conditions of skeletal muscle such as muscular dystrophies, non-dystrophic myopathies,
and sarcopenia.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jarrod A Call其他文献
Jarrod A Call的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jarrod A Call', 18)}}的其他基金
Pathological Foundations of Skeletal Muscle After Volumetric Muscle Loss and Targets For Rehabilitation
体积肌丢失后骨骼肌的病理学基础和康复目标
- 批准号:
10364333 - 财政年份:2022
- 资助金额:
$ 45.29万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 45.29万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 45.29万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 45.29万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 45.29万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 45.29万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 45.29万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 45.29万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 45.29万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 45.29万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 45.29万 - 项目类别:
Operating Grants